3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
11
Brain Neoplasms
3
Recurrence
2
Osteosarcoma
2
Multiple Myeloma
2
Medulloblastoma
2
Leukemia, Myeloid, Acute
2
Glioma
2
Glioblastoma
2
Diffuse Intrinsic Pontine Glioma
2
Xanthomatosis, Cerebrotendinous
1
Vaccinia
1
Uveal Melanoma
1
Transplant-Related Hematologic Malignancy
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Resectable Esophageal Cancer
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Oligodendroglioma
1
Neoplasms
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Interventions
Influenza Vaccines
2
Cyclophosphamide
2
thymoglobulin
1
fludarabine
1
baloxavir
1
Rituximab
1
Oseltamivir
1
Melphalan
1
Levetiracetam
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Diphtheria-Tetanus Vaccine
1
COVID-19 Vaccines
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Influenza, Human
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
1 year
×
Clear all
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled